×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ORIC – oric pharmaceuticals, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ORIC
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/17
05:01 pm
oric
ORIC® Pharmaceuticals Announces Preclinical Rinzimetostat (ORIC-944) Presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting
High
Report
ORIC® Pharmaceuticals Announces Preclinical Rinzimetostat (ORIC-944) Presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting
3/13
05:34 am
oric
Why ORIC Pharmaceuticals (ORIC) Is Down 15.1% After Ipsen Pulls Tazverik Over Safety Concerns [Yahoo! Finance]
Medium
Report
Why ORIC Pharmaceuticals (ORIC) Is Down 15.1% After Ipsen Pulls Tazverik Over Safety Concerns [Yahoo! Finance]
3/12
10:33 pm
oric
A Look At ORIC Pharmaceuticals (ORIC) Valuation After Recent Share Price Volatility [Yahoo! Finance]
Medium
Report
A Look At ORIC Pharmaceuticals (ORIC) Valuation After Recent Share Price Volatility [Yahoo! Finance]
3/9
04:05 pm
oric
Oric Pharmaceuticals (ORIC) had its "overweight" rating reaffirmed by Cantor Fitzgerald.
Medium
Report
Oric Pharmaceuticals (ORIC) had its "overweight" rating reaffirmed by Cantor Fitzgerald.
3/6
04:30 pm
oric
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
High
Report
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
2/25
11:03 am
oric
Oric Pharmaceuticals price target raised to $25 from $23 at H.C. Wainwright [Yahoo! Finance]
Low
Report
Oric Pharmaceuticals price target raised to $25 from $23 at H.C. Wainwright [Yahoo! Finance]
2/24
10:58 am
oric
Oric Pharmaceuticals (NASDAQ:ORIC) had its price target raised by analysts at HC Wainwright from $23.00 to $25.00. They now have a "buy" rating on the stock.
Medium
Report
Oric Pharmaceuticals (NASDAQ:ORIC) had its price target raised by analysts at HC Wainwright from $23.00 to $25.00. They now have a "buy" rating on the stock.
2/24
08:54 am
oric
Oric Pharmaceuticals (NASDAQ:ORIC) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $20.00 price target on the stock.
High
Report
Oric Pharmaceuticals (NASDAQ:ORIC) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $20.00 price target on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
2/23/2026
04:05 pm
oric
oric pharmaceuticals, inc.
BEAT
Report
14.6%
oric pharmaceuticals, inc.
11/13/2025
04:10 pm
oric
oric pharmaceuticals, inc.
BEAT
Report
2.3%
oric pharmaceuticals, inc.
8/12/2025
04:05 pm
oric
oric pharmaceuticals, inc.
MISS
Report
3.3%
oric pharmaceuticals, inc.
5/5/2025
04:05 pm
oric
oric pharmaceuticals, inc.
BEAT
Report
-11.4%
oric pharmaceuticals, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
2/26
04:48 pm
oric
Form 4 Oric Pharmaceuticals, For: Feb 24 Filed by: Piscitelli Dominic
Low
Report
Form 4 Oric Pharmaceuticals, For: Feb 24 Filed by: Piscitelli Dominic
2/24
04:09 pm
oric
Form 144 Oric Pharmaceuticals, Filed by: Piscitelli Dominic
Low
Report
Form 144 Oric Pharmaceuticals, Filed by: Piscitelli Dominic
2/23
05:06 pm
oric
Form 8-K Oric Pharmaceuticals, For: Feb 23
High
Report
Form 8-K Oric Pharmaceuticals, For: Feb 23
2/23
05:03 pm
oric
Form 424B5 Oric Pharmaceuticals,
High
Report
Form 424B5 Oric Pharmaceuticals,
2/23
04:16 pm
oric
Form 10-K Oric Pharmaceuticals, For: Dec 31
High
Report
Form 10-K Oric Pharmaceuticals, For: Dec 31
2/23
04:10 pm
oric
Form 8-K Oric Pharmaceuticals, For: Feb 23
High
Report
Form 8-K Oric Pharmaceuticals, For: Feb 23
2/17
06:15 pm
oric
Form SCHEDULE 13G/A Oric Pharmaceuticals, Filed by: Venrock Healthcare Capital Partners III, L.P.
Medium
Report
Form SCHEDULE 13G/A Oric Pharmaceuticals, Filed by: Venrock Healthcare Capital Partners III, L.P.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: